Faes Farma ( (ES:FAE) ) has shared an update.
Faes Farma has announced its updated Remuneration Policy for directors, approved by the General Shareholders’ Meeting with significant support. The policy, effective from September 1, 2024, reflects changes in the company’s organizational structure and aims to align with strategic priorities and governance standards. The policy includes procedures for determining and approving director remuneration, with input from external advisors and consideration of internal and external factors.
More about Faes Farma
Faes Farma, S.A. operates in the pharmaceutical industry, focusing on the development, production, and commercialization of pharmaceutical products. The company is headquartered in Leioa, Vizcaya, and is known for aligning its strategic priorities with shareholder interests and corporate governance recommendations.
YTD Price Performance: 6.09%
Average Trading Volume: 11,156
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €1.14B
Find detailed analytics on FAE stock on TipRanks’ Stock Analysis page.